OncoMatch/Clinical Trials/NCT07650656
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Is NCT07650656 recruiting? Yes, currently enrolling (Sep 2026). This Phase 2 trial studies Indocyanine Green for high grade sarcoma.
Treatment: Indocyanine Green
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Indocyanine Green
Cancer type
Sarcoma
Disease stage
Grade: intermediate to high
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- City of Hope Medical Center · Duarte, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07650656 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages